FTSE 100 Index rises but pound slumps on 'Brexit' fears
The FTSE 100 Index increased 11.54 points to 6556.91
Company
Scancell Holdings PLC
LON:SCLP
Scancell is a clinical stage biotech company developing immunotherapies for a cancer-free future by enhancing long-lasting tumour specific immunity. With deep roots in cancer immunology and translational research, the company aims to translate its innovation and creativity to address the need for fast, potent and accessible therapies that are easy to administer in hard-to-treat cancers.
329 stories · page 15 of 17
Scancell Holdings says SCIB1 survival data is compelling
Chief executive Dr Richard Goodfellow told investors that the drug continues to deliver compelling survival data in patients
London stocks gain after labour costs inhibit UK rate hikes, after rough Brexit week
The FTSE100 index popped its head above 6,000 early in the session and managed to stay there into the Friday close, drawing and end to a difficult Brexit fears week
FTSE 100 back above 6,000 level
Footsie is on track to finish a rough week on a positive note
Risers and Fallers: Thor Mining, Churchill Mining, Chariot Oil ...
Main share price risers and fallers in London at 3.45pm
Scancell working quickly to secure new supplies of drug
The company said that quality control analysis revealed the “stored drug product is no longer within the original specification”.
FTSE 100 off to a flyer as investors pile into banking stocks
Banks lead the way higher as fears of a Brexit recede
Scancell's immunotherapy platform to fight brain cancer
Glioblastoma multiforme is one of the most common and most aggressive forms of brain cancer.
Blue-chip shares slide while Aim stocks thrive
The FTSE 100 surrendered all of May's gains to close 10 points down on the month
Small-cap pharma stocks rise but FTSE 100 Index treads water
The FTSE 100 Index trod water as traders shrugged off mixed economic data from the continent
Flat finish for the Footsie as Fed announcement looms
Today was effectively a wash-out for equities, with the Footsie barely changed
Proactive news highlights: Breedon Aggregates, Capital Drilling, Haydale, Scancell and more...
Strategic Minerals begins drilling in Australia, Haydale agrees a partnership with plasma reactor group and Scancell has a management reshuffle.
Investments and investor services
FTSE 100 Index falls but Goals Soccer Centres scores high
Footsie falls 40 points but Goals Soccer Centres lifts nearly 10%
Investments and investor services
Mining stocks drag Footsie lower, while Aim also struggles
Mining stocks weighed on the Footsie but Capital Drilling offered some hope for the beleaguered sector
AstraZeneca tipped to bid for US cancer specialist
AstraZeneca has reportedly held talks with San Francisco-based Medivation
Scancell Holdings PLC brings in £6.2mln in fundraise
Scancell Holdings PLC revealed it had raised a total of around £6.2mln from its open offer and share placing. n.
Archive
Proactive news summary: Keywords Studios PLC, Scancell Holdings PLC, Metal Tiger PLD and more
Keywords Studios unlocks China, Metal Tiger shares rise and a successful fundraiser from cancer-fighting Scancell.
SyndicateRoom’s crowdfunding for AIM’s Scancell marks significant milestone
"We have pioneered this new model of share distribution - giving brokers and companies access to previously untapped retail demand,” said Tom Hinton, SyndicateRoom's head of capital markets.
Archive
Proactive news summary: Akers Biosciences Inc, Cluff Natural Resources PLC, Fastjet PLC and more
Fastjet mulls response to shareholder, Shanta Gold reaches a milestone and BATM was back in the black.
Scancell Holdings PLC to present at World Vaccine Congress
Dr Peter Brown, Scancell's clinical and scientific consultant on Immunotherapeutics, will give a presentation entitled: "SCIB1 ImmunoBody stimulates a potent T cell response that eradicates tumours and prevents recurrence".